Camp4 Therapeutics (CAMP) EBT Margin (2023 - 2026)
Camp4 Therapeutics recorded quarterly EBT Margin of 939.8% in Q1 2026, up 72.89% quarter-over-quarter from 3467.24% in Q4 2025, and up 51848.0% year-over-year from N/an in Q1 2025.
Camp4 Therapeutics' EBT Margin history runs 4 years deep, the most recent figure standing at 939.8% for Q1 2026.
- In Q1 2026, EBT Margin rose 51848.0% year-over-year to 939.8%; the TTM figure through Mar 2026 stood at 1271.73% (up 215250.0% YoY), while the FY2025 annual figure was 1445.77%, up 649764.0% from the prior year.
- EBT Margin came in at 939.8% for Q1 2026 at Camp4 Therapeutics, up from 3467.24% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 840.01% in Q2 2025 to a low of 3467.24% in Q4 2025.
- A 4-year average of 1963.94% and a median of 1663.9% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin slumped 143058 bps in 2025 and soared 51848 bps in 2026, its largest moves.
- Camp4 Therapeutics' EBT Margin stood at 3341.71% in 2023, then jumped by 39 bps to 2036.66% in 2024, then plunged by 70 bps to 3467.24% in 2025, then soared by 73 bps to 939.8% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 939.8%, 3467.24%, and 1663.9% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -6.40% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 41.95% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 23.05% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 18.99% |
| 10 | Camp4 Therapeutics | 245.89 Mn | 245.89 Mn | - | -939.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -939.80% |
| Dec 31, 2025 | -3,467.24% |
| Sep 30, 2025 | -1,663.90% |
| Jun 30, 2025 | -840.01% |
| Mar 31, 2025 | -1,458.28% |
| Dec 31, 2024 | -2,036.66% |
| Sep 30, 2023 | -3,341.71% |